BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18794110)

  • 21. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
    Spencer ES; Dale EJ; Gommans AL; Rutledge MT; Vo CT; Nakatani Y; Gamble AB; Smith RA; Wilbanks SM; Hampton MB; Tyndall JD
    Eur J Med Chem; 2015 Mar; 93():501-10. PubMed ID: 25743213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
    Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
    Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
    ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
    Guo D; Guo J; Yao J; Jiang K; Hu J; Wang B; Liu H; Lin L; Sun W; Jiang X
    Int J Cancer; 2016 Nov; 139(9):2056-67. PubMed ID: 27434219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
    Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
    Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
    Xiao DZ; Dai B; Chen J; Luo Q; Liu XY; Lin QX; Li XH; Huang W; Yu XY
    Cell Prolif; 2011 Dec; 44(6):582-90. PubMed ID: 21991924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
    Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
    Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
    Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M; Yamamoto S; Katayama N; Fujita S
    Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease.
    Nishihira J
    Ann N Y Acad Sci; 2012 Oct; 1271(1):53-7. PubMed ID: 23050964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
    Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
    Coleman AM; Rendon BE; Zhao M; Qian MW; Bucala R; Xin D; Mitchell RA
    J Immunol; 2008 Aug; 181(4):2330-7. PubMed ID: 18684922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
    Al-Abed Y; Dabideen D; Aljabari B; Valster A; Messmer D; Ochani M; Tanovic M; Ochani K; Bacher M; Nicoletti F; Metz C; Pavlov VA; Miller EJ; Tracey KJ
    J Biol Chem; 2005 Nov; 280(44):36541-4. PubMed ID: 16115897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
    Kostevich VA; Sokolov AV; Grudinina NA; Zakharova ET; Samygina VR; Vasilyev VB
    Biometals; 2015 Oct; 28(5):817-26. PubMed ID: 26091949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
    Wang Z; Wei M; Wang M; Chen L; Liu H; Ren Y; Shi K; Jiang H
    Inflammation; 2014 Dec; 37(6):2020-9. PubMed ID: 24958012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
    El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
    Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway.
    Cao F; Xiao Z; Chen S; Zhao C; Chen D; Haisma HJ; Dekker FJ
    Bioorg Chem; 2021 Dec; 117():105396. PubMed ID: 34649152
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Liao CH; Yong CY; Lai GM; Chow JM; Cheng CF; Fang CL; Lin PC; Chang CL; Zheng YM; Chuang SE; Whang-Peng J; Yao CJ
    Am J Chin Med; 2020; 48(6):1491-1509. PubMed ID: 32924531
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury.
    Lu H; Bai Y; Wu L; Hong W; Liang Y; Chen B; Bai Y
    Mediators Inflamm; 2016; 2016():2174682. PubMed ID: 27313397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.